All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Utilization of high-resolution mass spectrometry and data-independent analysis to track the monoclonal antibody spatial stability

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F25%3A00619327" target="_blank" >RIV/61388971:_____/25:00619327 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11310/25:10502969

  • Result on the web

    <a href="https://www.tandfonline.com/doi/full/10.1080/14789450.2025.2492763" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/14789450.2025.2492763</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1080/14789450.2025.2492763" target="_blank" >10.1080/14789450.2025.2492763</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Utilization of high-resolution mass spectrometry and data-independent analysis to track the monoclonal antibody spatial stability

  • Original language description

    Objectives: Chemical cross-linking coupled with mass spectrometry (CXMS) offers the distance constraints critical for building the structural model of protein and protein complexes and understanding dynamics of biological systems. Originally developed for protein structural models, CXMS has evolved into method for studying protein complex formation, ligand-induced conformational changes, and quantitative structural analysis using isotopically labeled cross-linkers. Methods: In this study we tested the potential of isotopically labeled MS-cleavable cross-linker to track the stability of the therapeutic monoclonal antibodies. Results: A novel isotopically labeled MS-cleavable cross-linker was synthesized, and its reactivity was successfully tested on peptide and protein standards. Further, the novel cross-linker was utilized to test the stability of selected therapeutical monoclonal antibodies, bevacizumab and trastuzumab, adopting the data-independent acquisition. Conclusion: This study reports the advantages of using combination of 13C isotopically labeled MS-cleavable cross-linkers and data-independent mass spectrometry analysis for the automated identification of cross-linked products and thus monitoring the structural rearrangement of protein structure.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Expert Review of Proteomics

  • ISSN

    1478-9450

  • e-ISSN

    1744-8387

  • Volume of the periodical

    22

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    199-207

  • UT code for WoS article

    001471295500001

  • EID of the result in the Scopus database

    2-s2.0-105003147151